Sintx Technologies Inc (SINT): Kapitalisasi marang pendapatan

Simbol lan logo merek SINTX Technologies (SINT)

Sintx Technologies (SINT) is developing a mature portfolio of silicon nitride products, expanding the application of ceramics in energy and defense systems. The company's leadership is based on the creation of antibacterial nanostructures for implants. High processing precision is achieved through the robotization of sintering and grinding. P/S levels on this chart reflect the business valuation dynamics, where the parameter has stabilized at 3.20.

SINT Multiplikator P/S SINTX Technologies (04.07.2022 - 13.11.2026)

Rincian analitis perusahaan Sintx Technologies (SINT)

- rega saham lan konsensus proyeksi valuasi:
Analisis umum perusahaan:SINT Sintx Technologies Inc
Barang utama Sintx Technologies, Inc.

The P/S multiple reflects the market value of one ruble of revenue by comparing the total market capitalization of a business with its sales volume. Investors analyze this ratio to identify whether an asset is undervalued relative to its operational scale. The current P/S valuation helps determine if the market is overpaying for a company with a high dependency on external raw material suppliers. For Sintx Technologies (SINT), this indicator is critical, as distribution outsourcing directly impacts final turnover.

Pesaing Sintx Technologies

BSX (bostonscientific.com) - Rasio kapitalisasi pasar marang pendapatan|Rasio rega marang pendapatan Edwards Lifesciences Corporation EW|RMD - Kapitalisasi marang pendapatan|OmniPod - Multiplikator P/S|Rega marang dodolan Zimmer Biomet Holdings|COO: Multiplikator P/S|Rasio kapitalisasi marang pendapatan ALGN|GMED (Globus Medical) - Multiplikator P/S|TransMedics Group Inc (TMDX) - Koefisien rega marang pendapatan|Multiplikator P/S ATEC|Kapitalisasi marang pendapatan Artivion Corp AORT|Multiplikator P/S ENOV (Enovis Corporation)|Multiplikator P/S integralife.com IART|ESTA - Rasio rega marang pendapatan|BBNX: Rasio rega marang pendapatan|IRMD (Iradimed) - Kapitalisasi marang pendapatan|Embecta Health - Rasio kapitalisasi pasar marang pendapatan|TNDM (Tandem Diabetes Care) - Multiplikator P/S|Rega marang dodolan axogeninc.com AXGN|Rasio rega marang pendapatan SI-BONE (SIBN)|Orthofix Medical (OFIX) - Multiplikator rega marang pendapatan|Bioventus Corp - Kapitalisasi marang pendapatan|Multiplikator P/S OrthoPediatrics Corp KIDS|Treace Medical Concepts - Multiplikator P/S|Koefisien rega marang pendapatan blade.com SRTA|Carlsmed (CARL) - Rasio rega marang pendapatan|Rasio rega marang dodolan RXST (RxSight Inc)|Rasio rega marang pendapatan ClearPoint Neuro Inc.|Kapitalisasi marang pendapatan Stereotaxis Corporation (STXS)|Multiplikator P/S STIM|SGHT - Rega marang dodolan|Rasio rega marang pendapatan Orchestra BioMed, Inc. OBIO|ANIK: Rasio kapitalisasi marang pendapatan|NSPR: Kapitalisasi marang pendapatan|Jin Medical International - Kapitalisasi marang volume dodolan|vivani.com (VANI) - Rasio rega marang pendapatan|XTNT - Koefisien rega marang pendapatan|NMTC (NeuroOne Medical Technologies Corporation) - Multiplikator P/S|Modular Med (MODD) - Koefisien rega marang pendapatan|Rasio rega marang pendapatan Myomo, Inc (MYO)|Envoy Medical Inc - Rasio kapitalisasi marang pendapatan|Vivos Therapeutics - Kapitalisasi marang pendapatan|Kapitalisasi marang volume dodolan NVNO (envveno.com)|TNON: Kapitalisasi marang pendapatan|LFWD (ReWalk Robotics) - Rasio kapitalisasi marang pendapatan|AMIX (autonomix.com) - Kapitalisasi marang pendapatan|INVO Fertility Corp - Rasio kapitalisasi pasar marang pendapatan|Kapitalisasi marang pendapatan BBLG|AXNX (axonics.com) - Kapitalisasi marang volume dodolan|Multiplikator P/S BIOL|DYNT - Rega marang dodolan|Multiplikator P/S FNA (Paragon 28)|INVO - Kapitalisasi marang pendapatan